REZDIFFRA (RESMETIROM)

**Product type:** Human Prescription Drug

**Active ingredient:** RESMETIROM

**Strength:** 100 mg/1

**Dosage form:** Tablet, Coated

**Route:** Oral

**Labeler:** Madrigal Pharmaceuticals, Inc.

**Marketing category:** NDA (NDA217785)

**Pharmacologic class:** Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Thyroid Hormone Receptor beta Agonist [EPC], Thyroid Hormone Receptor beta Agonists [MoA]